India and Armenia Sign Key MoU to Enhance Medical Product Regulation
On March 11, 2025, India and Armenia strengthened their bilateral ties by signing a significant Memorandum of Understanding (MoU) aimed at enhancing cooperation in the regulation of medical products. This agreement was formalized during the visit of Armenian Foreign Minister Ararat Mirzoyan to India.
The MoU was signed between India's Central Drugs Standard ControlOrganisation (CDSCO) and Armenia's Center of Drug and Medical Technology Expertise (CDMTE), marking a crucial step towards improved regulatory frameworks for medical products in both countries. The collaboration is expected to facilitate the exchange of best practices and enhance the safety and efficacy of medical products.
During his visit, Minister Mirzoyan held discussions with Indian External Affairs Minister S. Jaishankar, focusing on various aspects of India-Armenia relations, including trade, economy, education, and cultural exchanges. Both leaders expressed optimism about expanding cooperation in digital technologies and pharmaceuticals.
The MoU reflects a commitment to deeper bilateral engagement, underscoring the historical ties and mutual interests shared by India and Armenia. As both nations explore opportunities for collaboration, this agreement is poised to have a significant impact on the pharmaceutical sectors in both countries, ensuring better access to safe medical products for their populations.
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
FDA Sharpens the Dietary Supplement Ingredient Debate
-
FDA and NIH Launch a New Nutrition Science Partnership
-
FDA Reopens the Raw Manure Debate
-
EFSA Reviews Clodinafop Risk
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
Recommend Reading
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Syngenta Caught in Trade Crossfire
-
India Prepares New Seed and Pesticide Laws
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
2025 Review and 2026 Outlook of the Methanol Market in China
-
Geopolitical Premium Fades and Inventory Pressures Weigh on Oil Prices, Ending Five-Day Rally
-
Premium Global Chemical Sourcing Requests (10-14 Jan, 2026)
-
Early January Cyclohexanone Market in Shandong Fluctuates
-
Premium Global Chemical Sourcing Requests (11-13May, 2026)